Mechanisms of Activity of the TORC1 Inhibitor Everolimus in Waldenstrom Macroglobulinemia
Year: 2012
Type: article
Source: Clinical Cancer Research
Institutions: Harvard University, Dana-Farber Cancer Institute
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: U.S. Public Health Service
Award: G3462892656
OpenAlex ID: W2098608922
